哌啶-4-甲酰胺 → 1-(3-Methoxyphenyl)piperidine-4-carboxamide

HRID 297

反应方程式

HRID 297 反应方程式
COc1cccc(Br)c1.NC(=O)C1CCNCC1>CC(=O)O.CC(=O)O.CC(C)CN1CCN2CCN(CC(C)C)P1N(CC(C)C)CC2.C[Si](C)(C)[N-][Si](C)(C)C.Cc1ccccc1.[Li+].[Pd]>COc1cccc(N2CCC(C(N)=O)CC2)c1

参与物

7

反应条件

温度
100 °C

实验过程

piperidine-4-carboxamide (0.411 g, 3.21 mmol); 1-bromo-3-methoxybenzene (0.339 mL, 2.67 mmol) and diacetoxypalladium (0.120 g, 0.53 mmol) were thoroughly placed under an inert atmoshere. To this was added 2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (0.037 g, 0.11 mmol); LITHIUM BIS(TRIMETHYLSILYL)AMIDE (6.15 mL, 6.15 mmol) and toluene (10 mL). The resultant mixture was stirred at 100 °C overnight. No sign of reaction by LCMS overnight. Abandoned

来源与证据

ORD记录
ord-c91f5415f0604adda8f4b73dd97ab0f8
来源数据集
750 AstraZeneca ELN dataset
原始链接
查看来源

关联笔记

加载中…